Noile-Immune Biotech Inc. (TYO:4893)

Noile-Immune Biotech Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3,918	4,670	5,555	4,520	4,140
Cash & Short-Term Investments	3,918	4,670	5,555	4,520	4,140
Cash Growth	-16.10%	-15.93%	22.90%	9.18%	62.48%
Other Receivables	26	62	66	-	53
Receivables	26	62	66	-	53
Inventory	2	8	20	3	4
Prepaid Expenses	21	29	38	27	25
Other Current Assets	16	6	38	34	3
Total Current Assets	3,983	4,775	5,717	4,584	4,225
Long-Term Investments	28	24	61	56	45
Other Long-Term Assets	-	1	-	1	1
Total Assets	4,011	4,800	5,778	4,641	4,271
Accounts Payable	-	-	1	-	-
Accrued Expenses	31	27	29	45	20
Current Income Taxes Payable	39	32	48	235	51
Other Current Liabilities	4	10	8	55	9
Total Current Liabilities	74	69	86	335	80
Other Long-Term Liabilities	6	7	6	7	6
Total Liabilities	80	76	92	342	86
Common Stock	4,047	4,047	4,045	2,787	2,537
Additional Paid-In Capital	4,025	4,025	4,023	2,765	2,515
Retained Earnings	-4,147	-3,353	-2,389	-1,259	-872
Comprehensive Income & Other	6	5	7	6	5
Shareholders' Equity	3,931	4,724	5,686	4,299	4,185
Total Liabilities & Equity	4,011	4,800	5,778	4,641	4,271
Net Cash (Debt)	3,918	4,670	5,555	4,520	4,140
Net Cash Growth	-16.10%	-15.93%	22.90%	9.18%	62.48%
Net Cash Per Share	90.48	107.86	133.96	115.40	108.06
Filing Date Shares Outstanding	43.3	43.3	43.3	39.58	38.31
Total Common Shares Outstanding	43.3	43.3	43.3	39.58	38.31
Working Capital	3,909	4,706	5,631	4,249	4,145
Book Value Per Share	90.78	109.09	131.33	108.60	109.23
Tangible Book Value	3,931	4,724	5,686	4,299	4,185
Tangible Book Value Per Share	90.78	109.09	131.33	108.60	109.23

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.